BioNTech SE - ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:PFE) after the company issued FY23 guidance below estimates. Also, the Biden Administration said it plans to end COVID-19 emergency declarations on May 11.
See Also: Biden Administration Plans To End COVID-19 Public Health Emergency In May
Pfizer's FY23 Outlook
Pfizer forecasts FY23 sales to fall to $67-$71 billion from $100 billion in 2022 versus the consensus of $74.13 billion.
The company expects adjusted EPS guidance of $3.25-$3.45, down from $6.58 in 2022 and the consensus of $4.44...Read More
According to data from Benzinga Pro:
- BNTX shares are trading lower by 2.63% to $136.80
- MRNA is lower by 2.69% to $176.00
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
